When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mainly used to make the site work as you expect it to. The information does not directly identify you but can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. However, blocking some types of cookies may impact your experience of the site. You can find more information, including a detailed cookie explanation, on our Cookie Policy.
Transparency Portal
Institutional and organizational information
Key applicable regulations
Below we highlight key regulations that Quibim must comply with based on its operations. We are committed to upholding the highest level of compliance in all areas.
-
Regulation 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices.
-
Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data.
-
Legislative Royal Decree 1/2010, of July 2, approving the revised text of the Spanish Companies Act.
-
Law 14/2007, of 3 July, on Biomedical Research.
-
What Quibim does?
At Quibim, we partner with top-tier biopharma companies and healthcare institutions to apply AI techniques to medical images, extracting the latest insights into cancer and other diseases to unlock new data that can lead to prognostic or predictive models that connect research with personalized care.
The business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms. We are building an outstanding portfolio of tools for clinical use, including regulatory-cleared medical devices to extract objective and accurate information automatically.
Organizational structure and profiles of our leadership
Agreements entered into with public institutions and other grants
Information updated on November 15, 2023